StockData
CytoDyn Inc. logo

CytoDyn Inc. (CYDY) stock

CYDYOTCPharmaceutical PreparationsFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 14, 2026Score 4/30
$0.25+0.02 (+9.53%)

Close on Oct 19, 2026Market cap $345.56MP/E –Yield –

CytoDyn operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

CytoDyn's operating income for the twelve months ending Aug 31, 2026 was -$40.21M. For fiscal 2026 it was -$38.58M, down 499.3% from the year before. The highest annual figure on record is $9.66M in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2026May 31, 2026-$38.58M-499.3%
FY2025May 31, 2025$9.66M–
FY2024May 31, 2024-$18.06M–
FY2023May 31, 2023-$40.58M–
FY2022May 31, 2022-$145.40M–
FY2021May 31, 2021-$104.60M–
FY2020May 31, 2020-$74.65M–
FY2019May 31, 2019-$55.85M–
FY2018May 31, 2018-$45.92M–
FY2017May 31, 2017-$27.33M–
FY2016May 31, 2016-$21.18M–
FY2015May 31, 2015-$19.60M–
FY2014May 31, 2014-$8.11M–
FY2013May 31, 2013-$7.99M–
FY2012May 31, 2012-$7.46M–
FY2011May 31, 2011-$3.70M–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Aug 31, 2026-$6.58M–
Q4 FY2026CQ2 2026May 31, 2026-$5.64M–
Q3 FY2026CQ1 2026Feb 28, 2026-$6.30M–
Q2 FY2026CQ4 2025Nov 30, 2025-$21.69M–
Q1 FY2026CQ3 2025Aug 31, 2025-$4.95M-122.0%
Q4 FY2025CQ2 2025May 31, 2025-$5.07M–
Q3 FY2025CQ1 2025Feb 28, 2025-$4.00M–
Q2 FY2025CQ4 2024Nov 30, 2024-$3.71M–
Q1 FY2025CQ3 2024Aug 31, 2024$22.44M–
Q4 FY2024CQ2 2024May 31, 2024-$6.63M–
Q3 FY2024CQ1 2024Feb 29, 2024-$3.41M–
Q2 FY2024CQ4 2023Nov 30, 2023-$3.40M–
Q1 FY2024CQ3 2023Aug 31, 2023-$4.61M–
Q2 FY2023CQ4 2022Nov 30, 2022-$23.16M–
Q1 FY2023CQ3 2022Aug 31, 2022-$9.71M–
Q4 FY2022CQ2 2022May 31, 2022-$79.05M–
Q3 FY2022CQ1 2022Feb 28, 2022-$19.40M–
Q2 FY2022CQ4 2021Nov 30, 2021-$25.32M–
Q1 FY2022CQ3 2021Aug 31, 2021-$21.64M–
Q4 FY2021CQ2 2021May 31, 2021-$23.64M–
Q3 FY2021CQ1 2021Feb 28, 2021-$30.79M–
Q2 FY2021CQ4 2020Nov 30, 2020-$24.50M–
Q1 FY2021CQ3 2020Aug 31, 2020-$25.57M–
Q4 FY2020CQ2 2020May 31, 2020-$27.82M–
Q3 FY2020CQ1 2020Feb 29, 2020-$22.08M–
Q2 FY2020CQ4 2019Nov 30, 2019-$12.12M–
Q1 FY2020CQ3 2019Aug 31, 2019-$12.63M–
Q4 FY2019CQ2 2019May 31, 2019-$13.80M–
Q3 FY2019CQ1 2019Feb 28, 2019-$12.87M–
Q2 FY2019CQ4 2018Nov 30, 2018-$15.69M–
Q1 FY2019CQ3 2018Aug 31, 2018-$13.49M–
Q4 FY2018CQ2 2018May 31, 2018-$11.20M–
Q3 FY2018CQ1 2018Feb 28, 2018-$14.14M–
Q2 FY2018CQ4 2017Nov 30, 2017-$10.78M–
Q1 FY2018CQ3 2017Aug 31, 2017-$9.81M–
Q4 FY2017CQ2 2017May 31, 2017-$7.80M–
Q3 FY2017CQ1 2017Feb 28, 2017-$8.02M–
Q2 FY2017CQ4 2016Nov 30, 2016-$6.16M–
Q1 FY2017CQ3 2016Aug 31, 2016-$5.36M–

More CytoDyn figures

See a number that looks wrong?